IBDEI1DT ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,22349,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22349,1,3,0)
 ;;=3^Skin Cancer,Unspec
 ;;^UTILITY(U,$J,358.3,22349,1,4,0)
 ;;=4^C44.99
 ;;^UTILITY(U,$J,358.3,22349,2)
 ;;=^5001094
 ;;^UTILITY(U,$J,358.3,22350,0)
 ;;=E11.9^^73^961^33
 ;;^UTILITY(U,$J,358.3,22350,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22350,1,3,0)
 ;;=3^DM Type 2 w/o Complications
 ;;^UTILITY(U,$J,358.3,22350,1,4,0)
 ;;=4^E11.9
 ;;^UTILITY(U,$J,358.3,22350,2)
 ;;=^5002666
 ;;^UTILITY(U,$J,358.3,22351,0)
 ;;=E11.40^^73^961^29
 ;;^UTILITY(U,$J,358.3,22351,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22351,1,3,0)
 ;;=3^DM Type 2 w/ Neuropathy,Unspec
 ;;^UTILITY(U,$J,358.3,22351,1,4,0)
 ;;=4^E11.40
 ;;^UTILITY(U,$J,358.3,22351,2)
 ;;=^5002644
 ;;^UTILITY(U,$J,358.3,22352,0)
 ;;=E78.2^^73^961^58
 ;;^UTILITY(U,$J,358.3,22352,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22352,1,3,0)
 ;;=3^Hyperlipidemia,Mixed
 ;;^UTILITY(U,$J,358.3,22352,1,4,0)
 ;;=4^E78.2
 ;;^UTILITY(U,$J,358.3,22352,2)
 ;;=^78424
 ;;^UTILITY(U,$J,358.3,22353,0)
 ;;=E78.5^^73^961^59
 ;;^UTILITY(U,$J,358.3,22353,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22353,1,3,0)
 ;;=3^Hyperlipidemia,Unspec
 ;;^UTILITY(U,$J,358.3,22353,1,4,0)
 ;;=4^E78.5
 ;;^UTILITY(U,$J,358.3,22353,2)
 ;;=^5002969
 ;;^UTILITY(U,$J,358.3,22354,0)
 ;;=E66.3^^73^961^78
 ;;^UTILITY(U,$J,358.3,22354,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22354,1,3,0)
 ;;=3^Overweight
 ;;^UTILITY(U,$J,358.3,22354,1,4,0)
 ;;=4^E66.3
 ;;^UTILITY(U,$J,358.3,22354,2)
 ;;=^5002830
 ;;^UTILITY(U,$J,358.3,22355,0)
 ;;=D64.9^^73^961^5
 ;;^UTILITY(U,$J,358.3,22355,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22355,1,3,0)
 ;;=3^Anemia,Unspec
 ;;^UTILITY(U,$J,358.3,22355,1,4,0)
 ;;=4^D64.9
 ;;^UTILITY(U,$J,358.3,22355,2)
 ;;=^5002351
 ;;^UTILITY(U,$J,358.3,22356,0)
 ;;=F17.200^^73^961^75
 ;;^UTILITY(U,$J,358.3,22356,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22356,1,3,0)
 ;;=3^Nicotine Dependence,Unspec
 ;;^UTILITY(U,$J,358.3,22356,1,4,0)
 ;;=4^F17.200
 ;;^UTILITY(U,$J,358.3,22356,2)
 ;;=^5003360
 ;;^UTILITY(U,$J,358.3,22357,0)
 ;;=F17.229^^73^961^72
 ;;^UTILITY(U,$J,358.3,22357,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22357,1,3,0)
 ;;=3^Nicotine Dependence,Chewing Tobacco
 ;;^UTILITY(U,$J,358.3,22357,1,4,0)
 ;;=4^F17.229
 ;;^UTILITY(U,$J,358.3,22357,2)
 ;;=^5003374
 ;;^UTILITY(U,$J,358.3,22358,0)
 ;;=F19.10^^73^961^91
 ;;^UTILITY(U,$J,358.3,22358,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22358,1,3,0)
 ;;=3^Substance Abuse,Unspec
 ;;^UTILITY(U,$J,358.3,22358,1,4,0)
 ;;=4^F19.10
 ;;^UTILITY(U,$J,358.3,22358,2)
 ;;=^5003416
 ;;^UTILITY(U,$J,358.3,22359,0)
 ;;=F15.10^^73^961^90
 ;;^UTILITY(U,$J,358.3,22359,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22359,1,3,0)
 ;;=3^Stimulant Abuse,Unspec
 ;;^UTILITY(U,$J,358.3,22359,1,4,0)
 ;;=4^F15.10
 ;;^UTILITY(U,$J,358.3,22359,2)
 ;;=^5003282
 ;;^UTILITY(U,$J,358.3,22360,0)
 ;;=F43.21^^73^961^3
 ;;^UTILITY(U,$J,358.3,22360,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22360,1,3,0)
 ;;=3^Adjustment d/o w/ Depressed Mood
 ;;^UTILITY(U,$J,358.3,22360,1,4,0)
 ;;=4^F43.21
 ;;^UTILITY(U,$J,358.3,22360,2)
 ;;=^331948
 ;;^UTILITY(U,$J,358.3,22361,0)
 ;;=G43.909^^73^961^71
 ;;^UTILITY(U,$J,358.3,22361,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22361,1,3,0)
 ;;=3^Migraine,Unspec
 ;;^UTILITY(U,$J,358.3,22361,1,4,0)
 ;;=4^G43.909
 ;;^UTILITY(U,$J,358.3,22361,2)
 ;;=^5003909
